Inventor · disambiguated record
Nima Soleymanlou
Also filed as: SOLEYMANLOU NIMA
5 granted patents·19 pending applications·39 citations·filing 2005–2025
79Inventor score
Top patents by PatentIndex Score
24 records- 0196US11666590B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jun 6, 2023·9 cites·32 claims
- 0293US9949997B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 24, 2018·27 cites·18 claims
- 0390US11813275B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Granted Nov 14, 2023·2 cites·7 claims
- 0487US12427162B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Granted Sep 30, 2025·0 cites·16 claims
- 0587US11918596B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Granted Mar 5, 2024·1 cites·12 claims
- 0680US2022226360A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0772US2024156848A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0871US2020138844A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 0969US2025345352A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 1067US2019134072A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1165US2020360412A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1265US2018169126A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1365US2025057829A1Inhibitors of trpc6 for treating focal segmental glomerulosclerosisBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1464US2017333465A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1563US2014315832A1Pharmaceutical composition, methods for treating and uses thereofBROEDL ULI CHRISTIAN·Filed 2014·Application pending·0 cites
- 1661US2019038654A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1760US2020368261A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1859US2019015437A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1959US2016038525A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 2058US2014303097A1Pharmaceutical composition, methods for treating and uses thereofBROEDL ULI CHRISTIAN·Filed 2014·Application pending·0 cites
- 2154US2016000816A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 2250US2023149393A1Inhibitors of trpc6 for treating respiratory conditionsBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2350US2014038908A1Polynucleotides and Polypeptides Associated with Trophoblast Cell Death, Differentiation, Invasion and/or Cell Fusion and TurnoverMT SINAI HOSPITAL·Filed 2013·Application pending·0 cites
- 2443US2009239793A1Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnoverCANIGGIA ISABELLA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nima Soleymanlou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →